Effects of Progressive Muscle Relaxation and Mindfulness Meditation in Patients With Chronic Obstructive Pulmonary Disease

Hacettepe University65 enrolled

Overview

Patients with COPD will be entered. Participants will be randomized to one of three study arms: Arm 1: meditation; Arm 2: relaxation; Arm 3: Control. Hypothesis: Progressive muscle relaxation and mindfulness meditation will decrease severity of dyspnea, fatigue and care dependency.

Previous reports have revealed that progressive muscle relaxation and meditation are decreasing symptoms burden in chronic disease. On the other hand, no study has been conducted to determine the effects of progressive relaxation exercise and mindfulness meditation on dyspnea, fatigue and care dependency in patients with COPD. The present study investigates the effects of progressive muscle relaxation and mindfulness meditation in a single-site, 3-arm, assessor-blinded randomized, controlled study of 65 COPD patients. Arm 1: meditation; Arm 2: relaxation; Arm 3: Control.The investigators hypothesize that Progressive muscle relaxation and mindfulness meditation will decrease the severity of dyspnea, fatigue and care dependency.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

SINGLE

Enrollment

Conditions

COPD Mediation Fatigue Symptoms and Signs

Interventions

mindfullness and relaxationBEHAVIORAL

three arms: mindfullness and relaxation

Eligibility

Sex: ALLMin age: 40 Years

Medical Language ↔ Plain English

Inclusion Criteria: * older than 40 years * diagnosed with stage III-IV COPD * had at least primary school degree * had no cognitive dysfunction, or communication problems * were residing in Ankara. Exclusion Criteria: * history of cognitive dysfunction, or communication problems * illiteracy * applying any complementary and integrative approach during the study * participating in a pulmonary rehabilitation program during the study.

Locations (1)

Hacettepe University

Ankara, Altindag, Turkey (Türkiye)

Outcomes

Primary Outcomes

Change in dyspnea

Dyspnea will be measured by The Dyspnea-12 Scale. The range of total score was from 0 to 36, with higher scores demonstrating higher dyspnea level.

Time frame: Baseline measurements, at the end of 12th week and four weeks after the completion of the interventions

Change in fatigue

Quality of live will be measured by Asthma Fatigue Scale (CAFS). The CAFS scores is standardized to 0-100 in line with the following formula, (100 × (total score-minimum value to be obtained)/range), with higher scores indicating greater fatigue.

Time frame: Baseline measurements, at the end of 12th week and four weeks after the completion of the interventions

Change in care dependency

Quality of live will be measured by Care Dependency Scale (CDS). The sum of the scores changes from 17 to 85, with higher scores demonstrating lower dependence.

Time frame: Baseline measurements, at the end of 12th week and four weeks after the completion of the interventions

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.